The Motley Fool

Key Data Points

Primary metrics and data points about Keryx Biopharmaceuticals.
Current Price: $4.76
Prev Close: $5.06
Open: $4.98
Bid: $4.72
Ask: $5.00
Day's Range: $4.59 - $4.99
52wk Range: $4.59 - $18.30
Volume: 4,019,432
Avg Vol 1,794,297
Market Cap: $501M
P/E (ttm): -3.72
EPS (ttm): ($1.36)
Div & Yield: $0.00 (0.0%)

News and Headlines

Latest news about Keryx Biopharmaceuticals from

Business Summary

Industry, sector and description for Keryx Biopharmaceuticals.

A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

KERX vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Keryx Biopharmaceuticals.
CAPS Rating 2 out of 5
397 Outperform
65 Underperform
CAPS All Stars
59 Outperform
21 Underperform

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Ron Bentsur, CEO

0% Approve

Based on 0 Ratings

Powered by

More Details about Keryx Biopharmaceuticals

Primary metrics and data points about Keryx Biopharmaceuticals.